United States · Series D startup
7 rounds we have observed, with the 8 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$116Mraised across 7 rounds since 2006, from 7 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by finsmes.com
Reported by finance.yahoo.com
Reported by finsmes.com
From a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Alta Partners
Skyline VenturesAmgen
Lilly Ventures
Eli LillyCelgene
International Biotechnology Trust PlcMissing a round, or an investor who was in one? Tell us.
Sutro Biopharma's investors include SV Life Sciences, Alta Partners, Skyline Ventures, Amgen and Lilly Ventures, and 3 more on record.
Sutro Biopharma has raised $116M across 7 rounds since 2006.
Sutro Biopharma's most recent round was a Series D of $26M in Dec 2013.
Sutro Biopharma's largest round on record is $37M (Series C), in Nov 2010.
Sutro Biopharma's first round on record, in Jan 2006, was backed by SV Life Sciences.
Sutro Biopharma's latest named round is a Series D, in Dec 2013.
Sutro Biopharma is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
